Drug Utilization Study of Psychotropic Drugs in Outdoor Patients in a Teaching Hospital

Piparva, K. G.; Parmar, D. M.; Singh, A. P.; Gajera, M. V.; Trivedi, H. R.
January 2011
Indian Journal of Psychological Medicine;Jan-Jun2011, Vol. 33 Issue 1, p54
Academic Journal
Background: Psychotropic drugs have had a remarkable impact in psychiatric practice. However, their utilization in actual clinical practice, effectiveness and safety in real life situation need continuous study. Materials and Methods: A prospective cross sectional study was carried out for 6 months. Patients of all ages and both sexes were included in the study while inpatients, referred patients and patients of epilepsy were excluded. Using World Health Organization basic drug indicators, the prescribing pattern was analyzed. Results: The numbers of psychotropic drugs prescribed per patient were 2.96. Anti-anxiety drugs (82.83%) were most frequently prescribed psychotropic drugs in various psychiatric disorders. Usage of antipsychotic drugs was in 70.15% cases. Atypical antipsychotic drugs (43.83%) were prescribed more frequently than the typical antipsychotic drugs (26.32%). Prescribing frequency of selective serotonin reuptake inhibitors (36.66%) was more than the tricyclic antidepressant (21.96%) and atypical antidepressant drugs (1.83%) in major depression. Use of mood stabilizers was restricted only to bipolar mood disorders. Central anticholinergic drug was co-prescribed in as many as 88.15% patients receiving antipsychotic drugs. Conclusion: Anti-anxiety drug (Benzodiazepine (BZD)) usage was extensive in various psychiatry disorders. Rational use of BZD requires consideration/attention to dose and duration of usage as well as drug interactions with other psychotropic drugs. Routine use of central anticholinergic drug along with atypical antipsychotic drugs also, could not be justified.


Related Articles

  • 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. Baeken, Chris; D'haenen, Hugo; Flamen, Patrick; Mertens, John; Terriere, Dirk; Chavatte, Kris; Boumon, Rony; Bossuyt, Axel // European Journal of Nuclear Medicine;1998, Vol. 25 Issue 12, p1617 

    Abstract. 5-HT[sub 2A] receptors have been implicated in the pathophysiology of mood disorders and in the therapeutic effect of the so-called atypical antipsychotics. Recently, a new radioiodinated ligand with high affinity and selectivity for serotonin 5-HT[sub 2A] receptors, [sup 123]iodinated...

  • Promoter prognostication: the serotonin transporter gene and antidepressant response.  // Molecular Psychiatry;1998, Vol. 3 Issue 6, p475 

    The serotonin transporter has long been a focus of studies of mood disorders because of its role as a site of antidepressants. The recent cloning of the gene and identification of a functional polymorphism have fueled a new round of intriguing results regarding the gene's role in illness. These...

  • Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration. Aizat Zain, Mohd; Nusrat Jahan, Suffee; Reynolds, Gavin P.; Zuraida Zainal, Nor; Kanagasundram, Sharmilla; Mohamed, Mohamed // BMC Medical Genetics;2012, Vol. 13 Issue 1, p91 

    Background: One of the genes suggested to play an important role in the pathophysiology of bipolar disorder (BPD) is PDLIM5, which encodes LIM domain protein. Our main objective was to examine the effect of olanzapine treatment on PDLIM5 mRNA expression in the peripheral blood leukocytes of BPD...

  • Prospective Observation of Switching Rate of Antidepressants in Management of Depressive Episode in 3 Months. Weidong Jin; Naixin Wang; Yongchun Ma; Zhenhua Tong // Psychology (2152-7180);Mar2013, Vol. 4 Issue 3, p174 

    Objective: to observe prospectively of switching rate of antidepressants in management of depressive episode. Methods: 190 patients with depressive episode treated by antidepressants were observed for 3 months and switching rate were assessed under "best natural therapy". And switching criteria...

  • Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview. Pompili, Maurizio; Baldessarini, Ross J.; Forte, Alberto; Erbuto, Denise; Serafini, Gianluca; Fiorillo, Andrea; Amore, Mario; Girardi, Paolo // International Journal of Molecular Sciences;Oct2016, Vol. 17 Issue 10, p1 

    Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders as well as psychoses, stimulating interest in their possible contributions to altering suicidal risk. Clozapine remains the only treatment with an FDA-recognized indication for reducing suicidal risk (in...

  • The burden of psychotropic drug prescribingin people with dementia: a populationdatabase study. Guthrie, Bruce; Clark, Stella Anne; McCowan, Colin // Age & Ageing;Sep2010, Vol. 39 Issue 5, p637 

    Objective: to compare psychotropic prescribing in older people with dementia and the general elderly population. Design and setting: retrospective population database study in 315 General Practices. Subjects: there were 271,365 patients aged ⩾65, of which 10,058 (3.7%) recorded as having...

  • Industry withdrawal from psychiatric medication development. Klein, Donald F.; Glick, Ira D. // Revista Brasileira de Psiquiatria;Jul-Sep2014, Vol. 36 Issue 3, p259 

    Between 1950 and 1969, on a serendipitous basis, psychiatric drug development flourished. However, there has been a steep decline in the development of new medication classes. Instead of new molecular entities, slight molecular modifications producing "me-too" drugs attempted to garner market...

  • Effect of Clozapine on d-Fenfluramine-Evoked Neuroendocrine Responses in Schizophrenia and its Relationship to Clinical Improvement. Curtis, Vivienne A.; Wright, Pádraig; Reveley, Adrianne; Kerwin, Robert; Lucey, James V. // British Journal of Psychiatry;May95, Vol. 166, p642 

    Background. Clozapine is an effective antipsychotic that has high affinity for serotonin type 2 (5-HT2) receptors. The importance of 5-HI antagonism in the overall clinical efficacy of clozapine is unclear. Using a neuroendocrine strategy we tested the hypothesis that clinical response to...

  • New and Proposed Drugs for Mood Disorders. Ying, Patrick // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p65 

    There remains a significant need for new treatments for mood disorders. In the last 2 years, only one new drug has been approved for the treatment of major depressive disorder, desvenlafaxine; during this time, the other medications approved for the treatment of depression or bipolar disorder...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics